NTRR and Partners Explore the Cutting Edge of $1.7 Billion U.S. Medical Marijuana Sector
SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a provider of all-natural wellness solutions, announced today that, alongside new joint venture partner Field of View Technologies, the company is targeting cutting-edge innovations in smokeless delivery of medicinal cannabis in order to capture a share of the growing $1.7 billion U.S. medical marijuana (MMJ) sector.
As more and more patients nationwide turn to cannabis as a potent, natural remedy, the market for smoke-free delivery systems is booming. NTRR aims to help market and develop new smokeless technologies that will allow MMJ patients who want or need to avoid the respiratory risks associated with smoking.
"We're already looking into oral delivery, injections, topical treatments and other smokeless methods of MMJ therapy," said NTRR CEO Sydney Jim. "We believe this industry has truly arrived, and we plan to deliver the most effective, cutting-edge treatment solutions to a marketplace hungry for innovation."
In addition to its work with Field of View, NTRR is in negotiations with Vertigo Technologies, LLC, a Wyoming-based developer of cannabis post-production processes. If a definitive agreement is struck, NTRR could soon be assisting in the development and delivery of technologies and systems to make the delivery of medicinal cannabinoids to patients faster and more efficient than ever before.
By providing innovative products and services related to MMJ, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (CBIS), Medical Marijuana Inc. (MJNA) and Terra Tech Corp. (TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR's initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Sydney Jim, 813-367-2041
President and CEO
KEYWORDS: United States North America Florida
The article NTRR and Partners Explore the Cutting Edge of $1.7 Billion U.S. Medical Marijuana Sector originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.